US Patent Issued to Aclaris Therapeutics on May 13 for "Pyrrolopyrimidine ITK inhibitors" (Missouri, Illinois, Connecticut Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,203, issued on May 13, was assigned to Aclaris Therapeutics Inc. (Wayne, Pa.).

"Pyrrolopyrimidine ITK inhibitors" was invented by Eric Jon Jacobsen (Chesterfield, Mo.), David Randolph Anderson (Salem, Conn.), James Robert Blinn (O'Fallon, Mo.), Susan Landis Hockerman (Kirkwood, Mo.), Richard Heier (Columbia, Ill.) and Paramita Mukherjee (Carbondale, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are arylpyridinone compounds and compositions useful in the treatment of ITK mediated diseases, such as inflammation, having the structures of Formulas (I)-(IV):wherein the R groups, m, n, and X are as defined in the detailed descriptio...